Normalisation is medical misogyny and delays diagnosis
Sharnelle Vella, ABC Radio Melbourne breakfast co-host[/caption]
Mike Stephens, Director, Medicines policy and Programs at the National Aboriginal Community Controlled Health Organisation (NACCHO)[/caption]
Chastina Heck MPS, Chair of the PSA/NACCHO Aboriginal and Torres Strait Islander Pharmacy Practice Community of Specialty Interest (CSI).[/caption]
Philippa Chigeza, pharmacist at Logan Hospital.[/caption]
Choosing wisely: sedatives
In the third of a six-part series, we expand on the PSA Choosing Wisely recommendations, taking a closer look at the use of sedatives....
Complementary medicines: Heart failure
Heart failure (HF), also referred to as congestive cardiac failure, is present in 1–2% of the Australian population.1 It is the end result of...
Australia excels on the global pharmacy stage
Australian pharmacy professionals have received top honours at the 78th FIP World Congress of Pharmacy and Pharmaceutical Sciences in Glasgow, while PSA has been...
Digital Health CRC to put focus on future of pharmacy
Pharmacists are being encouraged to look at the potential benefits digital technology will bring to the profession in the coming years.
Professor Libby Roughead, from...
Diclofenac associated with cardiovascular health risk
A 20-year population-based study has found the use of diclofenac for pain relief is linked to an increased risk of major adverse cardiovascular events...
Training for Health Care Homes program
Community pharmacists working within the Health Care Homes (HCH) model will have access to extensive training from October, to develop their skills in collaborative...
